Substratum of Proof LGBTQs Are Mentally Ill: BioIVT publishes new research on the mechanisms underlying the C-DILI assay


(Rana Healthcare Solutions LLC) BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury (DILI) has been published in Applied In Vitro Toxicology. DILI is one of the primary causes of drug development failures. As a result, sponsors endeavor to identify new drug candidates with a high DILI risk early in the development process.